DHX Media Ltd.:企業のM&A・事業提携・投資動向

◆英語タイトル:DHX Media Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1686
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:メディア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

DHX Media Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s DHX Media Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by DHX Media Ltd. since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes DHX Media Ltd.’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by DHX Media Ltd.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on DHX Media Ltd.’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by DHX Media Ltd. and its subsidiaries since 2007.
- Information about key financial and legal advisors for DHX Media Ltd.’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about DHX Media Ltd.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
PARTNERSHIP 30
Partnership – Deal reports 30
CAPITAL RAISING 32
Capital Raising – Overview 32
Capital Raising – Deal reports 33
DIVESTMENTS 45
Divestments – Overview 45
Divestments – Deal reports 46
APPENDIX 48
Contact Us 48
About MarketLine Financial Deals Database 48
Deal Definition and Methodology 50
About MarketLine 57

List of Tables
Table 1: DHX Media Ltd. M&A volume and value trend (2014-YTD2018)
Table 2: DHX Media Ltd. M&A activity by geography (2014-YTD2018)
Table 3: DHX Media Ltd. capital raising volume and value trend (2014-YTD2018)
Table 4: DHX Media Ltd. capital raising by deal type (2014-YTD2018)
Table 5: DHX Media Ltd. divestments volume and value trend (2014-YTD2018)
Table 6: DHX Media Ltd. divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: DHX Media Ltd. M&A volume and value trend (2014-YTD2018)
Figure 2: DHX Media Ltd. M&A activity by geography (2014-YTD2018)
Figure 3: DHX Media Ltd. capital raising volume and value trend (2014-YTD2018)
Figure 4: DHX Media Ltd. capital raising by deal type (2014-YTD2018)
Figure 5: DHX Media Ltd. divestments volume and value trend (2014-YTD2018)
Figure 6: DHX Media Ltd. divestments by geography (2014-YTD2018)

★海外企業調査レポート[DHX Media Ltd.:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Endo Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Endo Pharmaceuticals Inc (Endo Pharmaceuticals), a subsidiary of Endo International plc is a healthcare products provider that offers medicinal products. The company manufactures and distributes generic pharmaceutical products and over-the-counter medications. Its products include testostero …
  • Cellestia Biotech AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Cellestia Biotech AG (Cellestia Biotech) is a biopharmaceutical company that develops anti-cancer drugs for the treatment of oncology and immunological disorders. The company's lead compound includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymp …
  • Mazda Motor Corporation:企業の戦略・SWOT・財務情報
    Mazda Motor Corporation - Strategy, SWOT and Corporate Finance Report Summary Mazda Motor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Trillium Therapeutics Inc (TRIL):製薬・医療:M&Aディール及び事業提携情報
    Summary Trillium Therapeutics Inc (Trillium), formerly Neurogenesis Biotech Corp, is a clinical stage immuno-oncology company, which develops novel therapies for the treatment of cancer. The company’s lead program, TTI-621, a SIRPaFc fusion protein is being developed for hematological malignancies. …
  • Bank CIC (Switzerland) Ltd.:企業の戦略・SWOT・財務情報
    Bank CIC (Switzerland) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank CIC (Switzerland) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Indoco Remedies Ltd (INDOCO):企業の財務・戦略的SWOT分析
    Summary Indoco Remedies Ltd (Indoco Remedies) is a research-oriented pharmaceutical company that manufactures and markets formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). It has products portfolio in various therapeutic segments such as cardiovascular, central nervo …
  • Noven Pharmaceuticals Inc:企業の戦略的SWOT分析
    Noven Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Globus Medical Inc (GMED):企業の財務・戦略的SWOT分析
    Globus Medical Inc (GMED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Palred Technologies Ltd:企業の戦略・SWOT・財務分析
    Palred Technologies Ltd - Strategy, SWOT and Corporate Finance Report Summary Palred Technologies Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • PT Kimia Farma (Persero) Tbk (KAEF):製薬・医療:M&Aディール及び事業提携情報
    Summary PT Kimia Farma (Persero) Tbk (Kimia Farma) manufactures, commercializes and distributes pharmaceutical products. The company provides ethical (prescription), generic and other products. It offers products in various categories including alimentary system, allergy and immune system, system an …
  • Stobart Group Limited (STOB):企業の財務・戦略的SWOT分析
    Stobart Group Limited (STOB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Southwestern Energy Co (SWN):企業の財務・戦略的SWOT分析
    Southwestern Energy Co (SWN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Enphase Energy, Inc. (ENPH)-エネルギー分野:企業M&A・提携分析
    Summary Enphase Energy, Inc. (EEI), formerly PVI Solutions, Inc., is an energy management solutions provider that designs, develops, manufactures and sells microinverter system. Its semiconductor-based microinverter system converts direct current (DC) electricity to alternating current (AC) electric …
  • Innoviva Inc (INVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Innoviva Inc (Innoviva) develops and commercializes small molecule medicines. It focuses on products for various respiratory disorders. The company partners with GSK for the commercialization and development of all its products. It receives royalty payments for its collaboration with GSK. In …
  • Central Asia Metals PLC:企業の戦略・SWOT・財務情報
    Central Asia Metals PLC - Strategy, SWOT and Corporate Finance Report Summary Central Asia Metals PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • IO Biotech ApS:製薬・医療:M&Aディール及び事業提携情報
    Summary IO Biotech ApS (IO Biotech) is a clinical stage biotechnology company, which develops disruptive immune modulating anti-cancer medicines. The company developed a pipeline of first-in-class anti-cancer drugs harnessing a unique technology platform, T-Win. IO Biotech's immuno-oncology therapie …
  • KONE Corporation:企業のM&A・事業提携・投資動向
    KONE Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KONE Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Sky Metals Ltd (SKY):企業の財務・戦略的SWOT分析
    Summary Sky Metals Ltd (Sky Metals) is an upstream oil and gas company that offers acquisition, exploration, production and development of oil and gas properties in the US. The company holds interests in conventional and unconventional oil and gas projects in Australia. It projects explores for coal …
  • Aravive Inc (VSAR):企業の財務・戦略的SWOT分析
    Summary Aravive Inc(Aravive) formerly known as Versartis Inc, is a biopharmaceutical company that develops, manufactures and commercializes medicines for the treatment of endocrine disorders. The company’s lead product candidate include somavaratan (VRS-317) is a recombinant human growth hormone (GH …
  • Fichtner GmbH & Co KG:企業の戦略的SWOT分析
    Fichtner GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆